{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:23Z","timestamp":1791827543545,"version":"4.3.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2024 National Clinical Key Specialty Construction Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"DOI":"10.1007\/s12325-026-03826-7","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:33:42Z","timestamp":1791826422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiorenal Protective Glucose-Lowering Treatment Patterns in Type 2 Diabetes Mellitus Based on a Real-World Study: A Clinical Phenotype Cluster Analysis"],"prefix":"10.1007","author":[{"given":"Wenjia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-0543","authenticated-orcid":false,"given":"Xiaoling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanwei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-2168","authenticated-orcid":false,"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"10397","key":"3826_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"1990","unstructured":"Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 1990;402(10397):203\u201334.","journal-title":"Lancet"},{"key":"3826_CR2","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2025","unstructured":"International Diabetes Federation. IDF diabetes atlas. 11th ed. Brussels, Belgium: International Diabetes Federation; 2025.","edition":"11th ed"},{"issue":"12","key":"3826_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11892-019-1239-x","volume":"19","author":"R Almourani","year":"2019","unstructured":"Almourani R, Chinnakotla B, Patel R, et al. Diabetes and cardiovascular disease: an update. Curr Diab Rep. 2019;19(12):161.","journal-title":"Curr Diab Rep"},{"issue":"10","key":"3826_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103588","volume":"14","author":"B Taurbekova","year":"2025","unstructured":"Taurbekova B, Sarsenov R, Yaqoob MM, et al. Cluster analysis in diabetes research: a systematic review enhanced by a cross-sectional study. J Clin Med. 2025;14(10):3588.","journal-title":"J Clin Med"},{"issue":"5","key":"3826_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3826_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","volume":"7","author":"X Zou","year":"2019","unstructured":"Zou X, Zhou X, Zhu Z, et al. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019;7(1):9\u201311.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"3826_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s13300-026-01879-z","volume":"17","author":"K Nyg\u00e5rd","year":"2026","unstructured":"Nyg\u00e5rd K, Ryh\u00e4nen R, Kortteenniemi A, et al. Identification of patient clusters with distinct disease progression patterns utilizing a nationwide Finnish population with type 2 diabetes. Diabetes Ther. 2026;17(7):1043\u201365.","journal-title":"Diabetes Ther"},{"issue":"1","key":"3826_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/dom.70222","volume":"28","author":"W Yang","year":"2026","unstructured":"Yang W, Cai X, Ji Q, et al. Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023\u20132024. Diabetes Obes Metab. 2026;28(1):497\u2013507.","journal-title":"Diabetes Obes Metab."},{"issue":"3","key":"3826_CR9","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s12325-025-03114-w","volume":"42","author":"X Cai","year":"2025","unstructured":"Cai X, Yang W, Feng B, et al. Real-world multicenter registry to determine management and quality of care of patients with type 2 diabetes, hypertension, heart failure and\/or chronic kidney diseases in China (iCaReMe China). Adv Ther. 2025;42(3):1600\u20139.","journal-title":"Adv Ther"},{"issue":"12","key":"3826_CR10","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"41","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669\u2013701.","journal-title":"Diabetes Care"},{"key":"3826_CR11","unstructured":"Chinese Diabetes Society. Guideline for the prevention and treatment of diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus. 2021;13(04):315\u2013409."},{"issue":"10 Suppl","key":"3826_CR12","first-page":"S181","volume":"30","author":"KC Ferdinand","year":"2024","unstructured":"Ferdinand KC. An overview of cardiovascular-kidney-metabolic syndrome. Am J Manag Care. 2024;30(10 Suppl):S181\u20138.","journal-title":"Am J Manag Care."},{"issue":"1","key":"3826_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00125-025-06565-6","volume":"69","author":"JMT Colombijn","year":"2026","unstructured":"Colombijn JMT, de Leijer JF, Visseren FLJ, et al. Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia. 2026;69(1):36\u201349.","journal-title":"Diabetologia"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03826-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:33:44Z","timestamp":1791826424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03826-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":13,"alternative-id":["3826"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03826-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wenjia Yang, Shuzhen Bai, Xiaoling Cai, Ming Liu, Qiuhe Ji, Yanbing Li, Bo Feng, Nanwei Tong, Han Wu, Jingya Yan, Wei Zhao, and Linong Ji received a modest fee to cover their clinical service, clinical work, data collection and reporting. All authors declare no other conflicts of financial interest for participation in this research.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The iCaReMe China study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board of Peking University People's Hospital and all participating centers (IRB approval number: 2023PHB063-001).\u00a0Informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}